🇺🇸 FDA
Patent

US 7326734

Treatment of bladder and urinary tract cancers

granted A61KA61K31/12A61K31/401

Quick answer

US patent 7326734 (Treatment of bladder and urinary tract cancers) held by The Regents of the University of California expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/12, A61K31/401, A61K31/405, A61K31/4172